Search research articles
Contact Us
Filters
Showing results (1-10 of 182) with videos related to
Page
of 19
Sort By:
Neurology
|
February 9, 2005
Reverse transcriptase takes ALS back to viruses
Wim Robberecht, Burk Jubelt
The Lancet. Neurology
|
February 26, 2011
Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease
Thomas Philips, Wim Robberecht
Nature Reviews. Neurology
|
October 15, 2014
The phenotypic variability of amyotrophic lateral sclerosis
Bart Swinnen, Wim Robberecht
Nature Reviews. Neuroscience
|
March 7, 2013
The changing scene of amyotrophic lateral sclerosis
Wim Robberecht, Thomas Philips
The New England Journal of Medicine
|
February 24, 2021
STING-Induced Inflammation - A Novel Therapeutic Target in ALS?
Philip Van Damme, Wim Robberecht
Expert Opinion on Investigational Drugs
|
May 13, 2014
Developments in treatments for amyotrophic lateral sclerosis via intracerebroventricular or intrathecal delivery
Philip Van Damme, Wim Robberecht
Current Opinion in Neurology
|
July 14, 2009
Recent advances in motor neuron disease
Philip Van Damme, Wim Robberecht
Methods in Molecular Biology (Clifton, N.J.)
|
September 14, 2011
Modeling neurodegenerative diseases in zebrafish embryos
Angela S Laird, Wim Robberecht
Current Opinion in Neurology
|
August 16, 2013
Clinical implications of recent breakthroughs in amyotrophic lateral sclerosis
Philip Van Damme, Wim Robberecht
Trends in Neurosciences
|
September 11, 2007
Heterogeneity in motoneuron disease
Diether Lambrechts, Wim Robberecht, Peter Carmeliet
Page
of 19
Search research articles
Search
Showing results (1-10 of 182) with videos related to
Sort By:
Page
of 19
Neurology
|
February 9, 2005
Reverse transcriptase takes ALS back to viruses
Wim Robberecht, Burk Jubelt
The Lancet. Neurology
|
February 26, 2011
Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease
Thomas Philips, Wim Robberecht
Nature Reviews. Neurology
|
October 15, 2014
The phenotypic variability of amyotrophic lateral sclerosis
Bart Swinnen, Wim Robberecht
Nature Reviews. Neuroscience
|
March 7, 2013
The changing scene of amyotrophic lateral sclerosis
Wim Robberecht, Thomas Philips
The New England Journal of Medicine
|
February 24, 2021
STING-Induced Inflammation - A Novel Therapeutic Target in ALS?
Philip Van Damme, Wim Robberecht
Expert Opinion on Investigational Drugs
|
May 13, 2014
Developments in treatments for amyotrophic lateral sclerosis via intracerebroventricular or intrathecal delivery
Philip Van Damme, Wim Robberecht
Current Opinion in Neurology
|
July 14, 2009
Recent advances in motor neuron disease
Philip Van Damme, Wim Robberecht
Methods in Molecular Biology (Clifton, N.J.)
|
September 14, 2011
Modeling neurodegenerative diseases in zebrafish embryos
Angela S Laird, Wim Robberecht
Current Opinion in Neurology
|
August 16, 2013
Clinical implications of recent breakthroughs in amyotrophic lateral sclerosis
Philip Van Damme, Wim Robberecht
Trends in Neurosciences
|
September 11, 2007
Heterogeneity in motoneuron disease
Diether Lambrechts, Wim Robberecht, Peter Carmeliet
Page
of 19